The role of factor V Leiden and prothrombin G20210A mutations in sudden sensorineural hearing loss

Kemal Görür1, Ulkü Tuncer, Gülçin Eskandari

  • 1Department of Otorhinolaryngology, University of Mersin School of Medicine, Mersin, Turkey. kgorur@mersin.edu.tr

Insights

Factor V Leiden mutation is linked to sudden sensorineural hearing loss (SSHL). This genetic risk factor was more prevalent in SSHL patients than controls, suggesting a potential role in the condition. Prothrombin G20210A showed no significant association.

Area of Science:

  • Genetics
  • Otolaryngology
  • Hematology

Background:

  • Sudden sensorineural hearing loss (SSHL) can result from microthromboangiopathy affecting cochlear blood supply.
  • Factor V Leiden and prothrombin G20210A mutations are known genetic risk factors for thrombotic microangiopathy.

Purpose of the Study:

  • To investigate the incidence of factor V Leiden and prothrombin G20210A mutations in patients with sudden sensorineural hearing loss (SSHL).

Main Methods:

  • A case-control study involving 56 SSHL patients and 95 controls.
  • Genomic DNA was analyzed for factor V Leiden and prothrombin G20210A mutations using polymerase chain reaction.

Main Results:

  • Factor V Leiden mutation was significantly more frequent in SSHL patients (16.1%) compared to controls (5.3%) (p=0.02).
  • No significant difference in prothrombin G20210A mutation incidence was observed between SSHL patients and controls.
  • All identified mutations were heterozygous.

Conclusions:

  • A significant association exists between factor V Leiden mutation and idiopathic SSHL.
  • Prothrombin G20210A mutation does not appear to correlate with the occurrence of idiopathic SSHL.
Abstract

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...